SCHEMBL854644

SCHEMBL854644

Cc1cccc2c(=O)[nH]c(-c3ccccc3)c(OCCNC(=O)OC(C)(C)C)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
IDO1 P14902 2/20 0.40
BCHE P06276 3/20 0.40
CNR2 P34972 2/20 0.40
SCN9A Q15858 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
PARP1 P09874 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP3A43 Q9HB55 1/20 0.38
CKS1B P61024 1/20 0.38
SKP1 P63208 1/20 0.38
SKP2 Q13309 1/20 0.38
PDK2 Q15119 1/20 0.37
PDCD1 Q15116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15467756 0.85 CYP1A1 (0.46) IDO1BCHECNR2CA12CA1
SCHEMBL853588 0.80 BCHE (0.41) IDO1BCHECNR2SCN9ACA12
SCHEMBL853576 0.80 PARP1 (0.55) SCN9APARP1CYP1A1CYP2D6CYP2B6
SCHEMBL15467774 0.80 BCHE (0.46) IDO1BCHECNR2CA12CA1
SCHEMBL853060 0.79 SERPINE1 (0.53) L3MBTL1BCHECNR2SCN9ACA12
SCHEMBL853536 0.78 PARP1 (0.50) PARP1
Hydrochloric Acid SCHEMBL854662 0.77 PARP1 (0.49) PARP1
SCHEMBL854015 0.77 BCHE (0.40) IDO1BCHECNR2SCN9ACA12
SCHEMBL21601421 0.76 L3MBTL1 (0.61) L3MBTL1IDO1SCN9ACA12CA1
SCHEMBL16227155 0.74 PARP1 (0.61) SCN9APARP1CYP1A1CYP2D6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993594-B2 Isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-03-31 US disclosed
US-20140045846-A1 ISOQUINOLIN-1(2H)-ONE DERIVATIVES AS PARP-1 INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2014-02-13 US disclosed
EP-2432765-A1 ISOQUINOLIN-1 (2H) -ONE DERIVATIVES AS PARP-1 INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2012-03-28 EP disclosed
WO-2010133647-A1 ISOQUINOLIN-1 (2H) -ONE DERIVATIVES AS PARP-1 INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045846-A1 ISOQUINOLIN-1(2H)-ONE DERIVATIVES AS PARP-1 INHIBITORS PARP1, PARP2, PARP11 L3MBTL1 2964/4885IDO1 202/4885BCHE 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.